Abbvie, Inc., et al, Astrazeneca Pharmaceuticals LP, Pharmaceutical Research and Manufacturers of America Vs Murrill 340B Court Decision

UNITED STATES DISTRICT COURT
WESTERN DISTRICT OF LOUISIANA
LAFAYETTE DIVISION
 

PHARMACEUTICAL RESEARCH AND         CASE NO. 6:23-CV-00997
MANUFACTURERS OF AMERICA  
VERSUS                                                      JUDGE ROBERT R. SUMMERHAYS
LIZ MURRILL                                              MAGISTRATE JUDGE
                                                                  CAROL B. WHITEHURST
*****************************************
ASTRAZENECA PHARMACEUTICALS LP   CASE NO. 6:23-CV-01042
VERSUS
LIZ MURRILL                                                                                       
*****************************************
ABBVIE, INC., ET AL                                   CASE NO. 6:23-CV-01307
VERSUS
LIZ MURRILL                            
*****************************************

MEMORANDUM RULING
 

          Presently before the Court in three related matters are: (1) Motions for Summary Judgment filed by Plaintiffs AstraZeneca Pharmaceuticals LP (“AstraZeneca”), AbbVie, Inc. (“AbbVie”), and Pharmaceutical Research and Manufacturers of America (“PRMA”) (collectively, “Plaintiffs”);1 (2) Cross Motions for Summary Judgment2 by defendant, Liz Murrill; and (3) Cross Motions for Summary Judgment3 by the intervenor, Louisiana Primary Care Association (“LPCA”). The Court held a consolidated hearing on the various motions on June 6, 2024. After oral arguments, the Court took all the motions under advisement.